NovoCure (NVCR) said Wednesday it has appointed Christoph Brackmann as its next chief financial officer.
Brackmann, former senior vice president of finance at Moderna, will join the firm immediately as a senior financial advisor and will transition to the role of CFO on Jan. 1, 2025, when current CFO, Ashley Cordova, becomes CEO, NovoCure said.
Price: 16.59, Change: -0.30, Percent Change: -1.78
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments